Do patients with a limited number of brain metastases need whole-brain radiotherapy in addition to radiosurgery?

Strahlentherapie und Onkologie

Volumn 188, Issue 8, 2012, Pages 702-706

  Rades, D ^a   Schild, S E ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Brain metastases; Neurocognitive function; Radiosurgery; Treatment outcomes; Whole brain radiotherapy

Indexed keywords

BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COGNITION; HUMAN; RADIOSURGERY; REVIEW; WHOLE BRAIN RADIOTHERAPY;

BRAIN NEOPLASMS; COGNITION DISORDERS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84864590869     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0093-4     Document Type: Review

References (28)

1. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491. (Pubitemid 43854963)
2. Aoyama H, Tago M, Kato N et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388-1395. (Pubitemid 47176822)
3. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037-1044.
4. Chidel MA, Suh JH, Reddy C et al (2000) Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47:993-999. (Pubitemid 30345598)
5. Chougule PB, Burton-Williams M, Saris S et al (2000) Randomized treatment of brain metastases with gamma knife radiosurgery, whole brain radiotherapy, or both. Int J Radiat Oncol Biol Phys 48 (Suppl 1):114.
6. Fokas E, Henzel M, Engenhart-Cabillic R (2010) A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients. Strahlenther Onkol 186:565-571.
7. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751. (Pubitemid 27181303)
8. Gore EM, Bae K, Wong SJ et al (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 29:272-278.
9. Khuntia D, Brown P, Li J et al (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24:1295-1304. (Pubitemid 46622033)
10. Kocher M, Maarouf M, Bendel M et al (2004) Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 180:263-267. (Pubitemid 38667745)
11. Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134-141.
12. Le Péchoux C, Laplanche A, Faivre-Finn C et al (2011) Prophylactic Cranial Irradiation (PCI) collaborative group. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 22:1154-1163.
13. Li J, Bentzen SM, Li J et al (2008) Relationship between neurocognitive function and quality of life after whole-brai radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71:64-70. (Pubitemid 351506468)
14. Meisner J, Meyer A, Polivka B et al (2010) Outcome of moderately dosed radiosurgery for limited brain metastases. Report of a single-center experience. Strahlenther Onkol 186:76-81.
15. Pirzkall A, Debus J, Lohr F et al (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563-3569. (Pubitemid 28506769)
16. Rades D, Dunst J, Schild SE (2008) A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 184:251-255. (Pubitemid 351572841)
17. Rades D, Kueter JD, Hornung D et al (2008) Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT + SRS) for one to three brain metastases. Strahlenther Onkol 184:655-662.
18. Rades D, Nadrowitz R, Buchmann I et al (2010) Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC). Strahlenther Onkol 186:458-462.
19. Rades D, Pluemer A, Veninga T et al (2007) Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Cancer 110:2285-2292. (Pubitemid 350100751)
20. Regine WF, Scott C, Murray K et al (2001) Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711-717.
21. Ruge MI, Kocher M, Maarouf M et al (2011) Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol 187:7-14.
22. Shehata MK, Young B, Reid B et al (2004) Stereotatic radiosurgery of 468 brain metastases < or = 2 cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87-93. (Pubitemid 38501511)
23. Shibamoto Y, Baba F, Oda K et al (2008) Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys 72:1168-1173.
24. Sneed PK, Lamborn KR, Forstner JM et al (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549-558. (Pubitemid 29107174)
25. Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526. (Pubitemid 34626488)
26. Sun A, Bae K, Gore EM et al (2011) Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 29:279-286.
27. Tsao M, Xu W, Sahgal A (2011) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer doi 10.10022/cncr.26515.
28. Varlotto JM, Flickinger JC, Niranjan A et al (2005) The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125-1132 (Pubitemid 40884427)